SPEG and dilated cardiomyopathy: Furthermore, human loss-of-function mutations in SPEG are associated with dilated cardiomyopathy [as reviewed in (Campbell et al., 2021)] suggesting reduced SPEG activity is a risk factor for cardiac pathology.